Pharmacophore mapping, 3D QSAR, docking, and ADME prediction studies of novel Benzothiazinone derivatives

Year : | Volume : 01 | Issue : | Page : –
By

    Jahaan Shaikh

Abstract

 Background
Tuberculosis is a major public health concern worldwide which is caused by Mycobacterium tuberculosis. DprE1
(Decaprenyl Phosphoryl Ribose 2’- Epimerase) is the most challenging target for development of novel anti-
tubercular agents because it is a small protein and located into cytoplasmic membrane. So, novel anti-TB drugs did
not bound effectively with it. DprE1 catalyzes the oxidation of the 2’ hydroxyl group of DPR (Decaprenyl
Phosphoryl D- Ribose) to give Ketoribose DPX (Decaprenyl Phosphoryl 2-Ketoribose). Benzothiazinone is the most
potent Pharmacophore as DprE1 inhibitors. BTZ043, BTZ038, PBTZ169 and TMC-207 (Bedaquiline) are clinical
trial drugs as DprE1 inhibitors.
 Objective
To develop novel Benzothiazinone derivatives by performing Pharmacophore mapping, 3D QSAR, docking and
ADME prediction studies.
 Method
Pharmacophore mapping of Pyrazolopyridine, Dinitrobenzamide, and Benzothiazinone derivatives gives
information about essential features required for producing a biological response. Benzothiazinone (Ligand code:
73) has the essential features with the Fitness score for active ligands- 3.000 and as a Reference Ligand.
(Pharmacophore Hypothesis: AHHRR_1). It is validated by ROC (Receiver Operating Characteristics) value as 0.71
which indicates perfect performance of Pharmacophore mapping. Benzothiazinone congeneric series are required for
building 3D QSAR model. The validation criteria of 3D QSAR Model- Standard Deviation is 0.1531, R 2 value is
0.9754, R 2 CV (Cross Validation) value is 0.2118, R 2 Scramble value is 0.9500, Stability value is 0.261, F value
(Variance) is 205.0 (For Training set), P value (Probability value) is 1.58e-23, Q 2 value is 0.7632 and Pearson-r
value is 0.8939 (For Test set). PBTZ129 is the Reference Molecule (MIC value- 0.00019 µM). The contour maps
indicate the positions at which steric, electrostatic, hydrophobic, H-bond acceptor and H-bond donor groups are
required for generating SAR.
 Result
Novel Benzothiazinone derivatives designed according to contour maps and their biological activities were
predicted. Docking scores (PDB ID- 4NCR) are good and amino acid interactions of novel Benzothiazinone
derivatives are matched with in-built ligand 26J. Docking validation was also performed by comparing RMSD
values of superimposed atoms of co-crystal ligand and its conformer.
 Conclusion
These novel molecules can be proposed for synthesis and biological evaluation.

Keywords: DprE1, Benzothiazinone, Pharmacophore mapping, 3D QSAR, Docking, ADME prediction.

How to cite this article: Jahaan Shaikh Pharmacophore mapping, 3D QSAR, docking, and ADME prediction studies of novel Benzothiazinone derivatives ijab ; :-
How to cite this URL: Jahaan Shaikh Pharmacophore mapping, 3D QSAR, docking, and ADME prediction studies of novel Benzothiazinone derivatives ijab {cited };:-. Available from: https://journals.stmjournals.com/ijab/article=/view=0

var fieldValue = “[user_role]”;
if (fieldValue == ‘indexingbodies’) {
document.write(‘Full Text PDF‘);
}
else if (fieldValue == ‘administrator’) { document.write(‘Full Text PDF‘); }
else if (fieldValue == ‘ijab’) { document.write(‘Full Text PDF‘); }
else { document.write(‘ ‘); }

References

Tuberculosis is a major public health concern worldwide which is caused by Mycobacterium tuberculosis. DprE1
(Decaprenyl Phosphoryl Ribose 2’- Epimerase) is the most challenging target for development of novel anti-
tubercular agents


Subscription Original Research
Volume
Issue
Received January 2, 2024
Accepted
Published

function myFunction2() {
var x = document.getElementById(“browsefigure”);
if (x.style.display === “block”) {
x.style.display = “none”;
}
else { x.style.display = “Block”; }
}
document.querySelector(“.prevBtn”).addEventListener(“click”, () => {
changeSlides(-1);
});
document.querySelector(“.nextBtn”).addEventListener(“click”, () => {
changeSlides(1);
});
var slideIndex = 1;
showSlides(slideIndex);
function changeSlides(n) {
showSlides((slideIndex += n));
}
function currentSlide(n) {
showSlides((slideIndex = n));
}
function showSlides(n) {
var i;
var slides = document.getElementsByClassName(“Slide”);
var dots = document.getElementsByClassName(“Navdot”);
if (n > slides.length) { slideIndex = 1; }
if (n (item.style.display = “none”));
Array.from(dots).forEach(
item => (item.className = item.className.replace(” selected”, “”))
);
slides[slideIndex – 1].style.display = “block”;
dots[slideIndex – 1].className += ” selected”;
}